| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 28.077 | 59.465 | 56.243 | 60.001 |
| Total Income - EUR | - | - | - | - | - | - | 28.242 | 59.538 | 56.243 | 65.440 |
| Total Expenses - EUR | - | - | - | - | - | - | 15.223 | 34.571 | 16.973 | 51.945 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 13.019 | 24.967 | 39.271 | 13.495 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 12.171 | 23.801 | 38.708 | 12.985 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Idoctor S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 583 | 585 | 583 | 580 |
| Current Assets | - | - | - | - | - | - | 26.236 | 49.506 | 85.911 | 96.710 |
| Inventories | - | - | - | - | - | - | 23.021 | 41.790 | 68.661 | 56.535 |
| Receivables | - | - | - | - | - | - | 0 | 1.336 | 796 | 8.912 |
| Cash | - | - | - | - | - | - | 3.215 | 6.380 | 16.454 | 31.263 |
| Shareholders Funds | - | - | - | - | - | - | 14.395 | 38.200 | 76.631 | 89.187 |
| Social Capital | - | - | - | - | - | - | 2.224 | 2.231 | 2.022 | 2.211 |
| Debts | - | - | - | - | - | - | 12.424 | 11.891 | 9.863 | 8.103 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9510 - 9510" | |||||||||
| CAEN Financial Year |
9512
|
|||||||||
Comments - Idoctor S.r.l.